The Epithelial Immune Response to Human Papillomavirus Infection
Pathogens · 09.05.2025 · 14 (5) · 464
DOI: 10.3390/pathogens14050464 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 09.05.2025. Verfasst von Shyantani Roy-Biswas und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Dunedin School of Medicine, University of Otago, P.O. Box 56, Dunedin 9054, New Zealand. Hauptthemen laut MEDLINE: Papillomavirus Infections, Papillomaviridae, Host-Pathogen Interactions. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 230 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The skin is a complex organ, containing an intricate network of immune cells that are crucial for host barrier function and defence against pathogens. Human papillomavirus (HPV) exclusively infects the skin, and its lifecycle is intimately associated with epithelial cell division and differentiation. There are over 450 HPV types, 12 of which are classified as carcinogenic. The primary focus of this review is the epithelial immune response to HPV infection of the cervix during the initial stages of infection, productive infection, and disease progression. During the early stages of infection, cells are HPV-positive; however, there are no attributable histological changes to the epithelium. The HPV-infected cells have the capacity for innate sensing and signalling through toll-like receptors in response to viral nucleic acids. However, HPV has evolved multiple mechanisms to evade the innate response. During productive infection, all viral antigens are expressed and there are visible histological changes to the epithelium, including koilocytosis. Disease regression is associated with Tbet positive cells in the infected epithelium and the presence of CD4 and CD8 T cells in the lamina propria. Disease progression is associated with the overexpression of the E6 and E7 oncoproteins after integration of viral genomes into the host chromosomal DNA. Histologically, the epithelium is less differentiated, and changes to cells include a higher nuclear-to-cytoplasmic ratio and an increased mitotic index. Immune changes associated with disease progression include increased numbers of cells expressing suppressor molecules, such as FoxP3, Blimp-1, and HMGB1, and myeloid cell infiltrates with an M2-like phenotype. This review highlights the gaps in the understanding of the immune response in HPV-positive cervical neoplasia, and in regression and progression of disease. This knowledge is critical for the development of effective immunotherapies that reliably cause HPV-positive cervical neoplasia to regress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Dunedin School of Medicine, University of Otago, P.O. Box 56, Dunedin 9054, New Zealand.
ORCID-Profile: Shyantani Roy-Biswas, Merilyn Hibma
Zitieren
APA
Roy-Biswas, S., & Hibma, M. (2025). The Epithelial Immune Response to Human Papillomavirus Infection. Pathogens, 14(5), 464. https://doi.org/10.3390/pathogens14050464
Vancouver
Roy-Biswas S, Hibma M. The Epithelial Immune Response to Human Papillomavirus Infection. Pathogens. 2025;14(5):464. doi:10.3390/pathogens14050464
BibTeX
@article{RoyBiswas2025,
author = {Roy-Biswas, Shyantani and Hibma, Merilyn},
title = {The Epithelial Immune Response to Human Papillomavirus Infection},
journal = {Pathogens},
year = {2025},
volume = {14},
number = {5},
pages = {464},
doi = {10.3390/pathogens14050464}
}
EUVIMED